Optimising Life Through Optimising Biology
Optimum Bio Innovations Limited (OBIL) is a Research and Development (R&D) company headquartered in Auckland, New Zealand.
OBIL has developed a proprietary platform technology – a group of technologies used as a base upon which other applications, processes or technologies are developed.
The Company’s objective is to make an active contribution to New Zealand’s future sustainable economic growth and jobs through the development and export of ethical, innovative and sustainable technologies.
The core technology, which is protected by trade secret, came about by way of accidental discovery while pursuing environmental science-related opportunities in 2012 – specifically in emission reduction. It was discovered that the technology was making oxygen more bio-available.
In 2014 the first medical application of the current OptiBio technology was born out of the Founder’s desperation to help his father manage debilitating symptoms from a range of life threatening illnesses. Measurable results were observed in improved pain management, circulation, wound recovery and mental acuity.
As a result, over the next three years (2014 – 2017) of experimental R&D, 100+ people were directly referred across a range of differing illnesses seeking symptom relief in one or more of the same areas.
OBIL was established in 2017.
The Company’s focus is on R&D – to develop application specific Proof Of Concepts (POCs) in New Zealand that, once validated, will be spun out into separate, wholly-owned subsidiaries, each run by a team of specialists.
By 2024, over 40,000 hours have gone into R&D – to determine how the technology can be adapted and applied to enhance many living organisms.
OptiRTP has been established as a human life sciences business, to commercialise our proprietary technology to advance the health and welfare of humans. OptiRTP has the exclusive right to use OBIL’s technology and its subsequent advances to build a global business of scale.
For more information, please visit: www.OptiRTP.com
Optimum Bio Equine Limited (OBET)
OBET is the second application to be commercialised shortly, utilising an equine version of OBIL’s proprietary photobiomodulation therapy – to help optimise a horse’s natural ability to recover, faster.
For more information, please visit: www.OBETSolutions.com
Proof of concept research projects
Optimisation of small- scale, in-home / backyard aquaponics systems through an integrated iOT solution.
Research is underway to determine the effect we can have on improving photosynthesis, nutritional value and yield.
As new proof of concept research passes internal bench-top testing, these projects will be listed here.
The expertise of the core OBIL team lies in Research & Development (R&D) – including highly skilled scientists and engineers working on ideas through to proof of concept. Most of the Exec team have been working closely together for well over a decade and share a genuine desire to help people.